Kenneth J. Zuerblis, Director at STEMLINE THERAPEUTICS INC (STML), bought 3,000 shares at $15.85 ($48K) on 2013-05-29, disclosed to the SEC on 2013-06-03.
Open-market purchase of $48k STML by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.85 | 600 | $10K | 19.8% |
| 2 | $15.86 | 500 | $8K | 16.5% |
| 3 | $15.86 | 1,000 | $16K | 33.0% |
| 4 | $16.38 | 200 | $3K | 6.8% |
| 5 | $16.38 | 700 | $11K | 23.9% |
| Total | $16.01 avg | 3,000 |
| $48K |
| 100% |
| Filing → |
| SVNT | BUY | 2011-09-16 | $20K | — | Filing → |